Literature DB >> 10704773

Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils.

S R Lee1, S P Kim, J E Kim.   

Abstract

The purpose of this study was to examine whether topiramate would reduce neuronal damage after transient global ischemia in the gerbils because topiramate blocks voltage sensitive sodium channels and non-N-methyl-D-aspartate receptors and enhances gamma-aminobutyric acid-mediated inhibitory transmission. Both common carotid arteries were occluded for 3 min with microaneurysmal clips. The gerbils were treated with topiramate (50, 100, or 200 mg/kg, i.p.) immediately after ischemia. Neuronal cell damage in the hippocampal CA1 region was evaluated quantitatively 7 days after ischemia. Topiramate at the dose of 50 mg/kg failed to reduce hippocampal neuronal damage. However, topiramate when administered at the dose of 100 or 200 mg/kg significantly reduced hippocampal neuronal damage in dose-dependent manner (P<0.001 and P<0.0005, respectively). These results suggest that topiramate has a neuroprotective effect against neuronal damage following global ischemia in the gerbils.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704773     DOI: 10.1016/s0304-3940(00)00847-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Failure of ischemic neuroprotection by potentiators of gamma-aminobutyric acid.

Authors:  Ken Madden; Wayne Clark; Nicola Lessov
Journal:  Clin Med Res       Date:  2003-04

Review 2.  A working model for hypothermic neuroprotection.

Authors:  Guido Wassink; Joanne O Davidson; Christopher A Lear; Sandra E Juul; Frances Northington; Laura Bennet; Alistair J Gunn
Journal:  J Physiol       Date:  2018-05-24       Impact factor: 5.182

3.  Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity.

Authors:  Barbara R Sommer; Erica L Mitchell; Tonita E Wroolie
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

4.  Topiramate and vitamin e modulate the electroencephalographic records, brain microsomal and blood antioxidant redox system in pentylentetrazol-induced seizure of rats.

Authors:  Mustafa Naziroğlu; Süleyman Kutluhan; Abdulhadi Cihangir Uğuz; Omer Celik; Ramazan Bal; Peter J Butterworth
Journal:  J Membr Biol       Date:  2009-06-10       Impact factor: 1.843

5.  Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy.

Authors:  Mustafa Nazıroglu
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

6.  Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms.

Authors:  Puneet Kumar; Anil Kumar
Journal:  Psychopharmacology (Berl)       Date:  2009-09-18       Impact factor: 4.530

Review 7.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

8.  Modulation by topiramate of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons.

Authors:  Claus F Poulsen; Timothy A Simeone; Thomas E Maar; Virginia Smith-Swintosky; H Steven White; Arne Schousboe
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

9.  Selenium and topiramate modulates brain microsomal oxidative stress values, Ca2+-ATPase activity, and EEG records in pentylentetrazol-induced seizures in rats.

Authors:  Mustafa Naziroğlu; Süleyman Kutluhan; Mustafa Yilmaz
Journal:  J Membr Biol       Date:  2008-10-24       Impact factor: 1.843

Review 10.  Topiramate: as monotherapy in newly diagnosed epilepsy.

Authors:  John Waugh; Karen L Goa
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.